BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 432 participants.

Also called NCT04408261

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 432 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04408261
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04408261. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-22 (actual); primary completion 2022-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome
Acronym
BOSS
Condition
Stroke, Ischemic
Condition
Angina Pectoris, Stable
Condition
Diabetic Peripheral Neuropathy
Intervention (Drug)
Buqitongluo Granule
Intervention (Drug)
Buqitongluo Granule Placebo
Intervention (Other)
Standard care
Lead sponsor
Dongzhimen Hospital, Beijing (class: other)
Collaborator
Affiliated Hospital of Changchun University of Chinese Medicine (class: other)
Collaborator
Affiliated Hospital of Shandong University of Traditional Chinese Medicine (class: other)
Collaborator
Chengdu University of Traditional Chinese Medicine (class: other)
Collaborator
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine (class: not stated)
Collaborator
First Affiliated Hospital of Heilongjiang Chinese Medicine University (class: other)
Collaborator
Second Affiliated Hospital of Heilongjiang University of Chinese Medicine (class: other)
Collaborator
The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine (class: other)
Collaborator
Hunan Academy of Traditional Chinese Medicine Affiliated Hospital (class: not stated)
Collaborator
The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine (class: not stated)
Collaborator
Shaanxi Buchang Pharmaceutical Co., Ltd (class: industry)
Collaborator
Beijing Chuanglikechuang Medical Technology Development Co., Ltd. (class: not stated)
Collaborator
Shanghai Youningwei Biotechnology Co., Ltd. (class: not stated)
Collaborator
Wuhan Zhizhi Medical Technology Co., Ltd. (class: not stated)
Collaborator
Wuhan Third Hospital (class: other)
Collaborator
Rizhao Hospital of Traditional Chinese Medicine (class: not stated)
Collaborator
First Affiliated Hospital of Guangxi Medical University (class: other)
Collaborator
People's Hospital of Guangxi Zhuang Autonomous Region (class: other)

Record details

Record id
cardio:ct-nct04408261
Content hash
977812b38cc9af236b4f881813a150c7c9d4285c8983232ecdbdd0eba5a4ca5b